Interleukin-33 Amplifies IgE Synthesis and Triggers Mast Cell Degranulation Via Interleukin-4 in Naïve Mice

Overview

Journal Allergy

Specialty Allergy & Immunology

Date 2012 Jun 19

PMID 22702477

Citations 60

Authors

M Komai-Koma

F Brombacher

P N Pushparaj

B Arendse

C McSharry

J Alexander

R Chaudhuri

N C Thomson

A N J McKenzie

I McInnes

F Y Liew

D Xu

Affiliations

Soon will be listed here.

Abstract

Background: The regulation and function of IgE in healthy individuals and in antigen-naïve animals is not well understood. IL-33 administration increases serum IgE in mice with unknown mechanism. We tested the hypothesis that IL-33 provides an antigen-independent stimulus for IgE production and mast cell degranulation.

Methods: IL-33 was administered to naïve wild-type (WT), nude and ST2(-/-) , IL-4(-/-) , IL4Rα(-/-) and T-or B-cell-specific IL-4Rα(-/-) mice. IgE and cytokines were quantified by ELISA. T- and B-lymphocyte numbers and CD40L expression were determined by flow cytometry. Anaphylaxis was measured by temperature, mast cell degranulation and histamine release.

Results: IL-33 enhanced IgE production in naïve WT, T-IL-4Rα(-/-) but not in ST2(-/-) , IL-4(-/-) , IL-4Rα(-/-) or B-cell-specific IL-4Rα(-/-) mice, demonstrating IL-33 specificity and IL-4 dependency. Moreover, IL-4 was required for IL-33-induced B-cell proliferation and T-cell CD40L expression, which promotes IgE production. IL-33-induced IL-4 production was mainly from innate cells including mast cells and eosinophils. IL-33 increased mast cell surface IgE and triggered degranulation and systemic anaphylaxis in allergen-naïve WT but not in IL-4Rα(-/-) mice.

Conclusion: IL-33 amplifies IgE synthesis and triggers anaphylaxis in naïve mice via IL-4, independent of allergen. IL-33 may play an important role in nonatopic allergy and idiopathic anaphylaxis.

Citing Articles

Update on the Treatment of Chronic Spontaneous Urticaria.

Kolkhir P, Fok J, Kocaturk E, Li P, Okas T, Marcelino J Drugs. 2025; .

PMID: 40074986 DOI: 10.1007/s40265-025-02170-4.

Targeting γc family cytokines with biologics: current status and future prospects.

Bick F, Blanchetot C, Lambrecht B, Schuijs M MAbs. 2025; 17(1):2468312.

PMID: 39967341 PMC: 11845063. DOI: 10.1080/19420862.2025.2468312.

IL-33 Sensitizes Mast Cells to PIEZO1 Stimulation Leading to Degranulation.

Kobayashi Y, Sakai K, Tran N, Ishimaru K, Sato T, Nakamura Y Allergy. 2024; 79(12):3517-3520.

PMID: 39545515 PMC: 11657013. DOI: 10.1111/all.16397.

Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren's syndrome, Graves' disease, myasthenia gravis, immune thrombocytopenia, autoimmune hemolytic anemia, dermatomyositis, and graft-versus-host disease, are....

Huang Y, Shih L, Hsieh T, Tsai K, Lu K, Liao M Virulence. 2024; 15(1):2404225.

PMID: 39267271 PMC: 11409508. DOI: 10.1080/21505594.2024.2404225.

Mast cells control lung type 2 inflammation via prostaglandin E-driven soluble ST2.

Alhallak K, Nagai J, Zaleski K, Marshall S, Salloum T, Derakhshan T Immunity. 2024; 57(6):1274-1288.e6.

PMID: 38821053 PMC: 11168874. DOI: 10.1016/j.immuni.2024.05.003.

References

Lenchner K, Grammer L . A current review of idiopathic anaphylaxis. Curr Opin Allergy Clin Immunol. 2003; 3(4):305-11. DOI: 10.1097/00130832-200308000-00012. View

Smithgall M, Comeau M, Yoon B, Kaufman D, Armitage R, Smith D . IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008; 20(8):1019-30. DOI: 10.1093/intimm/dxn060. View

Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone D . Regulation of mast cell survival by IgE. Immunity. 2001; 14(6):791-800. DOI: 10.1016/s1074-7613(01)00157-1. View

Zurawski G, De Vries J . Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 1994; 15(1):19-26. DOI: 10.1016/0167-5699(94)90021-3. View

Pecaric-Petkovic T, Didichenko S, Kaempfer S, Spiegl N, Dahinden C . Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood. 2008; 113(7):1526-34. PMC: 2644080. DOI: 10.1182/blood-2008-05-157818. View

Golden D . What is anaphylaxis?. Curr Opin Allergy Clin Immunol. 2007; 7(4):331-6. DOI: 10.1097/ACI.0b013e3281f8290c. View

Xu D, Chan W, Leung B, Huang F, Wheeler R, Piedrafita D . Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998; 187(5):787-94. PMC: 2212173. DOI: 10.1084/jem.187.5.787. View

Ali S, Huber M, Kollewe C, Bischoff S, Falk W, Martin M . IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A. 2007; 104(47):18660-5. PMC: 2141833. DOI: 10.1073/pnas.0705939104. View

Pearce N, Pekkanen J, Beasley R . How much asthma is really attributable to atopy?. Thorax. 1999; 54(3):268-72. PMC: 1745435. DOI: 10.1136/thx.54.3.268. View

10.

Finkelman F, Holmes J, Katona I, Urban Jr J, Beckmann M, Park L . Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990; 8:303-33. DOI: 10.1146/annurev.iy.08.040190.001511. View

11.

Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan T . IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005; 23(5):479-90. DOI: 10.1016/j.immuni.2005.09.015. View

12.

Strait R, Morris S, Smiley K, Urban Jr J, Finkelman F . IL-4 exacerbates anaphylaxis. J Immunol. 2003; 170(7):3835-42. DOI: 10.4049/jimmunol.170.7.3835. View

13.

Vercelli D, Jabara H, Arai K, Geha R . Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med. 1989; 169(4):1295-307. PMC: 2189234. DOI: 10.1084/jem.169.4.1295. View

14.

Komai-Koma M, Gilchrist D, McKenzie A, Goodyear C, Xu D, Liew F . IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol. 2011; 186(4):2584-91. DOI: 10.4049/jimmunol.1002103. View

15.

Miller A, Xu D, Asquith D, Denby L, Li Y, Sattar N . IL-33 reduces the development of atherosclerosis. J Exp Med. 2008; 205(2):339-46. PMC: 2271006. DOI: 10.1084/jem.20071868. View

16.

Galli S, Kalesnikoff J, Grimbaldeston M, Piliponsky A, Williams C, Tsai M . Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005; 23:749-86. DOI: 10.1146/annurev.immunol.21.120601.141025. View

17.

Kalesnikoff J, Huber M, Lam V, Damen J, Zhang J, Siraganian R . Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 2001; 14(6):801-11. DOI: 10.1016/s1074-7613(01)00159-5. View

18.

Luthi A, Cullen S, McNeela E, Duriez P, Afonina I, Sheridan C . Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity. 2009; 31(1):84-98. DOI: 10.1016/j.immuni.2009.05.007. View

19.

Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan C, Ying S . IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 2009; 183(10):6469-77. DOI: 10.4049/jimmunol.0901575. View

20.

McCoy K, Harris N, Diener P, Hatak S, Odermatt B, Hangartner L . Natural IgE production in the absence of MHC Class II cognate help. Immunity. 2006; 24(3):329-39. DOI: 10.1016/j.immuni.2006.01.013. View